Skip to main content
Monday, November 16, 2026Nov 16

CVS Health stock rises as judge completes Aetna deal review

In this May 30, 2019, file photo, signs advertise new products available inside a CVS store with the new HealthHUB in Spring, Texas. CVS Health swung back to a profit in the second quarter and raised its 2019 forecast beyond Wall Street expectations thanks partly to an influx of revenue from its recently acquired health insurance business. Shares of the drugstore chain and pharmacy benefit manager jumped early Wednesday, Aug. 7, after it detailed a better-than-expected quarterly performance. (AP Photo/David J. Phillip, File)
In this May 30, 2019, file photo, signs advertise new products available inside a CVS store with the new HealthHUB in Spring, Texas. CVS Health swung back to a profit in the second quarter and raised its 2019 forecast beyond Wall Street expectations thanks partly to an influx of revenue from its recently acquired health insurance business. Shares of the drugstore chain and pharmacy benefit manager jumped early Wednesday, Aug. 7, after it detailed a better-than-expected quarterly performance. (AP Photo/David J. Phillip, File)

Shares of CVS Health started climbing early Thursday, a day after a federal judge finally completed his review of the company’s roughly $69 billion acquisition of the health insurer Aetna.

U.S. District Judge Richard J. Leon said Wednesday in federal court filings that a plan requiring CVS to unload Aetna’s Medicare prescription drug coverage business to ease concerns about competition was within the public’s interest.

The companies announced their combination at the end of 2017. CVS representatives have said for months that the two businesses were operating “as one company” while waiting to hear whether Leon would back the proposal to sell the Medicare business to another insurer, WellCare Health Plans.

CVS Health Corp. stock was up nearly 2%, or $1.18, to $62.85 shortly before markets opened Thursday.